Mitotane is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenocortical carcinoma (ACC).
from FDA,2024.01
Mitotane is used for treatment Adrenal cortex carcinoma.【more】
Release date:2026-01-06Recommended:5
Understanding the applicability and usage of mitotane is of great significance f···【more】
Release date:2025-04-28Recommended:126
Understanding the indications of the drug is a prerequisite for rational drug us···【more】
Release date:2025-04-28Recommended:128
Treatment options for a specific endocrine disorder are often of clinical concer···【more】
Release date:2025-04-27Recommended:198
The commonly used dosage form of Mitotane is a tablet, which is an antineoplasti···【more】
Release date:2024-08-16Recommended:203
By inhibiting the synthesis of adrenocortical hormones, Mitotane slows or stops ···【more】
Release date:2024-08-16Recommended:239
Mitotane is a drug with a unique mechanism of action that plays an important rol···【more】
Release date:2024-08-16Recommended:240